Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Purinergic signaling modulates CD4+ T cells with cytotoxic potential during Trypanosoma cruzi infection
Gastón Bergero, … , Martin Rottenberg, Maria P. Aoki
Gastón Bergero, … , Martin Rottenberg, Maria P. Aoki
Published July 1, 2025
Citation Information: J Clin Invest. 2025;135(13):e186785. https://doi.org/10.1172/JCI186785.
View: Text | PDF
Research Article Immunology Infectious disease Inflammation

Purinergic signaling modulates CD4+ T cells with cytotoxic potential during Trypanosoma cruzi infection

  • Text
  • PDF
Abstract

Chagas disease, caused by Trypanosoma cruzi, is endemic to Latin America and is characterized by chronic inflammation of cardiac tissues due to parasite persistence. Hypoxia within infected tissues may trigger the stabilization of HIF-1 and be linked to ATP release. Extracellular ATP exhibits microbicidal effects but is scavenged by CD39 and CD73 ectonucleotidases, which ultimately generate adenosine (ADO), a potent immunosuppressor. Here, we comprehensively study the importance of HIF-1 stabilization and the CD39/CD73/ADO axis, on CD4+ T cells with the cytotoxic phenotype, in facilitating the persistence of T. cruzi. Myocardial infection induces prominent areas of hypoxia, which is concomitant with HIF-1α stabilization in T cells and linked to early expansion of CD39+CD73+CD4+ T cell infiltrating population. Functional assays further demonstrate that HIF-1 stabilization and CD73 activity are associated with impaired CD4+ T cell cytotoxic potential. RNA-Seq analysis reveals that HIF-1 and purinergic signaling pathways are overrepresented in cardiac tissues of patients with end-stage Chagas disease. The findings highlight a major effect of purinergic signaling on CD4+ T cells with potential cytotoxic capacity in the setting of T. cruzi infection and have translational implications for therapy.

Authors

Gastón Bergero, Yanina L. Mazzocco, Sebastian Del Rosso, Ruining Liu, Zoé M. Cejas Gallardo, Simon C. Robson, Martin Rottenberg, Maria P. Aoki

×

Figure 5

T.cruzi infection induces HIF-1α stabilization in T cells from target tissues.

Options: View larger image (or click on image) Download as PowerPoint

T.cruzi infection induces HIF-1α stabilization in T cells from target t...
C57BL/6J (WT) mice were infected with T. cruzi, and target tissues were obtained at the indicated time points after infection. (A and B) Inflammatory cytokine levels in the spleen (A) and cardiac (B) tissue of individual mice (n = 4 per time) at 0, 14, and 21 days postinfection (dpi) were measured by bead-based immunoassays and normalized to the total protein concentration. (C and D) The number of total spleen cells normalized to body weight (C) and the number of CD45+CD3+ cells in cardiac tissue normalized to tissue weight (D) at 0, 4, 7, 14, and 21 dpi (n = 5 per time). (E and F) Pimonidazole staining of spleen (E) or cardiac (F) tissue sections from noninfected and infected mice (17 dpi). Representative images of spleen (original magnification, ×7) and heart (original magnification, ×30) are shown (brown, pimonidazole adducts; arrowheads, infiltrating immune cells; open arrowhead, amastigote niche). Scale bars: 100 µm (E), 30 µm (F). (G) Expression of HIF-1α in CD3+ and CD4+ T cells from noninfected (No Inf, n = 3) and infected (14 dpi) (Inf, n = 4) spleens measured by flow cytometry. (H and I) MFIs of pimonidazole adduct (Hypoxyprobe) (H) and HIF-1α (I) expression in CD45+ and CD3+ cells in cardiac tissue from noninfected (No Inf, n = 3) and infected (17 dpi) (Inf, n = 4) mice measured by flow cytometry. One-way ANOVA followed by Tukey’s post hoc test was conducted for A and B. Independent t test was conducted for C, D, and G–I. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts